Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation

Fumiya Miyamura, Shinichi Kako, Hiroko Yamagami, Ken Sato, Miki Sato, Kiriko Terasako, Shun Ichi Kimura, Hideki Nakasone, Satoko Aoki, Shinya Okuda, Rie Yamazaki, Kumi Oshima, Kentaro Yoshinaga, Takakazu Higuchi, Junji Nishida, Toshio Demitsu, Akihiro Kakehashi, Yoshinobu Kanda

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, and young-onset ATLL. A 25-year-old female developed ATLL and underwent allogeneic hematopoietic stem cell transplantation (HSCT) in non-remission. She had chronic refractory eczema and corneal injury at the onset of ATLL. Remission of ATLL was achieved, and the HTLV-1 proviral load decreased after HSCT. In addition, her pre-existing eczema and corneal injuries almost disappeared. More than a year has passed since the transplantation was performed, and she has had no recurrence of either ATLL or lesions in the skin and eye. Her clinical course suggests a possible association between skin and eye lesions and HTLV-1 infection. Changes in the immunological condition after HSCT might play a key role. Special attention is needed when HTLV-1 carriers develop eye or skin lesions.

Original languageEnglish
Pages (from-to)397-401
Number of pages5
JournalInternational Journal of Hematology
Volume90
Issue number3
DOIs
Publication statusPublished - 2009 Oct 1
Externally publishedYes

Fingerprint

Adult T Cell Leukemia Lymphoma
Hematopoietic Stem Cell Transplantation
Eczema
Young Adult
Human T-lymphotropic virus 1
Skin
Therapeutics
Deltaretrovirus Infections
Dermatitis
Corneal Injuries
Transplantation
Viruses
T-Lymphocytes
Recurrence

Keywords

  • ATLL
  • Corneal injury
  • HSCT
  • HTLV-1
  • Infective dermatitis

ASJC Scopus subject areas

  • Hematology

Cite this

Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation. / Miyamura, Fumiya; Kako, Shinichi; Yamagami, Hiroko; Sato, Ken; Sato, Miki; Terasako, Kiriko; Kimura, Shun Ichi; Nakasone, Hideki; Aoki, Satoko; Okuda, Shinya; Yamazaki, Rie; Oshima, Kumi; Yoshinaga, Kentaro; Higuchi, Takakazu; Nishida, Junji; Demitsu, Toshio; Kakehashi, Akihiro; Kanda, Yoshinobu.

In: International Journal of Hematology, Vol. 90, No. 3, 01.10.2009, p. 397-401.

Research output: Contribution to journalArticle

Miyamura, F, Kako, S, Yamagami, H, Sato, K, Sato, M, Terasako, K, Kimura, SI, Nakasone, H, Aoki, S, Okuda, S, Yamazaki, R, Oshima, K, Yoshinaga, K, Higuchi, T, Nishida, J, Demitsu, T, Kakehashi, A & Kanda, Y 2009, 'Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation', International Journal of Hematology, vol. 90, no. 3, pp. 397-401. https://doi.org/10.1007/s12185-009-0406-2
Miyamura, Fumiya ; Kako, Shinichi ; Yamagami, Hiroko ; Sato, Ken ; Sato, Miki ; Terasako, Kiriko ; Kimura, Shun Ichi ; Nakasone, Hideki ; Aoki, Satoko ; Okuda, Shinya ; Yamazaki, Rie ; Oshima, Kumi ; Yoshinaga, Kentaro ; Higuchi, Takakazu ; Nishida, Junji ; Demitsu, Toshio ; Kakehashi, Akihiro ; Kanda, Yoshinobu. / Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation. In: International Journal of Hematology. 2009 ; Vol. 90, No. 3. pp. 397-401.
@article{81e4c5944c0845cda5ab6ee39441734e,
title = "Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation",
abstract = "Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, and young-onset ATLL. A 25-year-old female developed ATLL and underwent allogeneic hematopoietic stem cell transplantation (HSCT) in non-remission. She had chronic refractory eczema and corneal injury at the onset of ATLL. Remission of ATLL was achieved, and the HTLV-1 proviral load decreased after HSCT. In addition, her pre-existing eczema and corneal injuries almost disappeared. More than a year has passed since the transplantation was performed, and she has had no recurrence of either ATLL or lesions in the skin and eye. Her clinical course suggests a possible association between skin and eye lesions and HTLV-1 infection. Changes in the immunological condition after HSCT might play a key role. Special attention is needed when HTLV-1 carriers develop eye or skin lesions.",
keywords = "ATLL, Corneal injury, HSCT, HTLV-1, Infective dermatitis",
author = "Fumiya Miyamura and Shinichi Kako and Hiroko Yamagami and Ken Sato and Miki Sato and Kiriko Terasako and Kimura, {Shun Ichi} and Hideki Nakasone and Satoko Aoki and Shinya Okuda and Rie Yamazaki and Kumi Oshima and Kentaro Yoshinaga and Takakazu Higuchi and Junji Nishida and Toshio Demitsu and Akihiro Kakehashi and Yoshinobu Kanda",
year = "2009",
month = "10",
day = "1",
doi = "10.1007/s12185-009-0406-2",
language = "English",
volume = "90",
pages = "397--401",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation

AU - Miyamura, Fumiya

AU - Kako, Shinichi

AU - Yamagami, Hiroko

AU - Sato, Ken

AU - Sato, Miki

AU - Terasako, Kiriko

AU - Kimura, Shun Ichi

AU - Nakasone, Hideki

AU - Aoki, Satoko

AU - Okuda, Shinya

AU - Yamazaki, Rie

AU - Oshima, Kumi

AU - Yoshinaga, Kentaro

AU - Higuchi, Takakazu

AU - Nishida, Junji

AU - Demitsu, Toshio

AU - Kakehashi, Akihiro

AU - Kanda, Yoshinobu

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, and young-onset ATLL. A 25-year-old female developed ATLL and underwent allogeneic hematopoietic stem cell transplantation (HSCT) in non-remission. She had chronic refractory eczema and corneal injury at the onset of ATLL. Remission of ATLL was achieved, and the HTLV-1 proviral load decreased after HSCT. In addition, her pre-existing eczema and corneal injuries almost disappeared. More than a year has passed since the transplantation was performed, and she has had no recurrence of either ATLL or lesions in the skin and eye. Her clinical course suggests a possible association between skin and eye lesions and HTLV-1 infection. Changes in the immunological condition after HSCT might play a key role. Special attention is needed when HTLV-1 carriers develop eye or skin lesions.

AB - Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, and young-onset ATLL. A 25-year-old female developed ATLL and underwent allogeneic hematopoietic stem cell transplantation (HSCT) in non-remission. She had chronic refractory eczema and corneal injury at the onset of ATLL. Remission of ATLL was achieved, and the HTLV-1 proviral load decreased after HSCT. In addition, her pre-existing eczema and corneal injuries almost disappeared. More than a year has passed since the transplantation was performed, and she has had no recurrence of either ATLL or lesions in the skin and eye. Her clinical course suggests a possible association between skin and eye lesions and HTLV-1 infection. Changes in the immunological condition after HSCT might play a key role. Special attention is needed when HTLV-1 carriers develop eye or skin lesions.

KW - ATLL

KW - Corneal injury

KW - HSCT

KW - HTLV-1

KW - Infective dermatitis

UR - http://www.scopus.com/inward/record.url?scp=76449100085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449100085&partnerID=8YFLogxK

U2 - 10.1007/s12185-009-0406-2

DO - 10.1007/s12185-009-0406-2

M3 - Article

C2 - 19705056

AN - SCOPUS:76449100085

VL - 90

SP - 397

EP - 401

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -